Literature DB >> 8337826

Equine herpesviruses 2 and 5 are gamma-herpesviruses.

E A Telford1, M J Studdert, C T Agius, M S Watson, H C Aird, A J Davison.   

Abstract

Equine herpesviruses 2 and 5 (EHV-2 and EHV-5) have biological properties and genome structures that support their classification as members of the Betaherpesvirinae. In order to investigate whether this is supported by genetic data, we analysed the sequences of random DNA fragments and identified 25 EHV-2 and 28 EHV-5 genes that encode amino acid sequences with significant homology to proteins from other herpesviruses. Greatest similarity was to proteins specified by the gamma-herpesviruses Epstein-Barr virus (a gamma 1-herpesvirus) and herpesvirus saimiri (a gamma 2-herpesvirus), and the level of similarity was marginally greater to the latter. Also, like other gamma-herpesviruses, the EHV-2 and EHV-5 genomes are deficient in the CG dinucleotide, suggesting that latent genomes are methylated. EHV-2 and EHV-5 are related to each other more closely than they are to other herpesviruses, but are clearly distinct gamma-herpesviruses. The data support the establishment of at least one more subdivision of the gamma-herpesviruses (the gamma 3-herpesviruses).

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8337826     DOI: 10.1006/viro.1993.1400

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  17 in total

1.  Detection of new DNA polymerase genes of known and potentially novel herpesviruses by PCR with degenerate and deoxyinosine-substituted primers.

Authors:  B Ehlers; K Borchers; C Grund; K Frölich; H Ludwig; H J Buhk
Journal:  Virus Genes       Date:  1999       Impact factor: 2.332

2.  Detection and analysis of diverse herpesviral species by consensus primer PCR.

Authors:  D R VanDevanter; P Warrener; L Bennett; E R Schultz; S Coulter; R L Garber; T M Rose
Journal:  J Clin Microbiol       Date:  1996-07       Impact factor: 5.948

3.  Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas- and TNFR1-induced apoptosis.

Authors:  J Bertin; R C Armstrong; S Ottilie; D A Martin; Y Wang; S Banks; G H Wang; T G Senkevich; E S Alnemri; B Moss; M J Lenardo; K J Tomaselli; J I Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

4.  A single 13-kilobase divergent locus in the Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genome contains nine open reading frames that are homologous to or related to cellular proteins.

Authors:  J Nicholas; V Ruvolo; J Zong; D Ciufo; H G Guo; M S Reitz; G S Hayward
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

5.  The equine herpesvirus 2 E1 open reading frame encodes a functional chemokine receptor.

Authors:  G Camarda; G Spinetti; G Bernardini; C Mair; N Davis-Poynter; M C Capogrossi; M Napolitano
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

6.  Pathological changes in the spleens of gamma interferon receptor-deficient mice infected with murine gammaherpesvirus: a role for CD8 T cells.

Authors:  B M Dutia; C J Clarke; D J Allen; A A Nash
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

7.  Diagnosis of equine gammaherpesvirus 2 and 5 infections by polymerase chain reaction.

Authors:  G H Reubel; B S Crabb; M J Studdert
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

8.  Molecular evolution of herpesviruses: genomic and protein sequence comparisons.

Authors:  S Karlin; E S Mocarski; G A Schachtel
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

9.  Equine gammaherpesvirus 2 (EHV2) is latent in B lymphocytes.

Authors:  H E Drummer; G H Reubel; M J Studdert
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

10.  Development and Validation of a Quantitative PCR Method for Equid Herpesvirus-2 Diagnostics in Respiratory Fluids.

Authors:  Erika S Hue; Christine I Fortier; Aurélie M Laurent; Yann F Quesnelle; Guillaume D Fortier; Loïc J Legrand; Stephane L Pronost
Journal:  J Vis Exp       Date:  2016-03-17       Impact factor: 1.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.